Legal & General Group
FHTX icon

Legal & General Group’s Foghorn Therapeutics FHTX Stock Holding History

Legal & General Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Hold
2,985
– – ﹤0.01% 3232
2026
Q1 		$14.2K Sell
2,985
-393
-12% -$2.16K ﹤0.01% 3093
2025
Q4 		$18.2K Hold
3,378
– – ﹤0.01% 3064
2025
Q3 		$16.5K Sell
3,378
-170
-5% -$901 ﹤0.01% 3122
2025
Q2 		$16.7K Buy
3,548
+842
+31% +$3.52K ﹤0.01% 3088
2025
Q1 		$9.88K Hold
2,706
– – ﹤0.01% 3174
2024
Q4 		$12.8K Hold
2,706
– – ﹤0.01% 3192
2024
Q3 		$25.2K Sell
2,706
-118
-4% -$854 ﹤0.01% 2956
2024
Q2 		$16.2K Buy
2,824
+815
+41% +$4.86K ﹤0.01% 3109
2024
Q1 		$13.4K Hold
2,009
– – ﹤0.01% 3134
2023
Q4 		$13K Hold
2,009
– – ﹤0.01% 3186
2023
Q3 		$10K Sell
2,009
-500
-20% -$3.85K ﹤0.01% 3267
2023
Q2 		$17.7K Buy
2,509
+287
+13% +$2.01K ﹤0.01% 3161
2023
Q1 		$13.8K Hold
2,222
– – ﹤0.01% 3150
2022
Q4 		$14.2K Hold
2,222
– – ﹤0.01% 3214
2022
Q3 		$19K Hold
2,222
– – ﹤0.01% 3217
2022
Q2 		$30K Buy
2,222
+557
+33% +$7.19K ﹤0.01% 3113
2022
Q1 		$25K Buy
1,665
+60
+4% +$823 ﹤0.01% 3174
2021
Q4 		$37K Sell
1,605
-68
-4% -$977 ﹤0.01% 3097
2021
Q3 		$23K Sell
1,673
-49
-3% -$543 ﹤0.01% 3223
2021
Q2 		$18K Buy
1,722
+1,006
+141% +$11K ﹤0.01% 3325
2021
Q1 		$9K Hold
716
– – ﹤0.01% 3401
2020
Q4 		$15K Buy
+716
New +$13.7K ﹤0.01% 3196

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Legal & General Group's FHTX Position: Q2 2026 in Review

Legal & General Group held its Foghorn Therapeutics (FHTX) position steady in Q2 2026 at 2,985 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3232.

Legal & General Group first reported a position in FHTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $37K in Q4 2021. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Legal & General Group held 2,985 shares of Foghorn Therapeutics worth $14.6K as of Q2 2026.
  • Legal & General Group left its Foghorn Therapeutics share count unchanged in Q2 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3232 holding.
  • Legal & General Group first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Legal & General Group's Foghorn Therapeutics position peaked at $37K in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.